Industry Focus

On this week’s episode of Industry Focus: Financials host Jason Moser sits down with Brendan Mathews, VP of Motley Fool Ventures to talk about the latest in the world of venture capital along with a couple of smaller banks making big investment in technology and much more! SIVB, LOB, MAR

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

The first $50 is on LinkedIn. Just visit LinkedIn.com/fool

You've got questions, we've got answers. We go into the mailbag to take on listener questions like:

• How can I boost my monthly income?
• How many shares of a stock should I buy?
• How can I work at The Fool?

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

It’s been a hectic year in the auto industry, with the first nationwide strike in decades happening at the same time the industry is facing a cyclical slowdown and a major technological turning point. Motley Fool Senior Auto Analyst John Rosevear joins the show to break down what this means for the auto industry and the Big Three U.S. automakers.

Stocks Mentioned: F, VWAPY, GM, FCAU, PUGOY

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Cutera, Nervo, and Novocure are three of the best-performing med-tech stocks in 2019, up at least 94% so far. What’s driving the gains? And should investors put any of these stocks on their radar?   Stocks: CUTR, NVRO, NVCR   Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

IF Regular Dan Kline spent some time at Money 20/20 – a conference focused on the payments and fintech space. We recap his big takeaways on how BaaS (banking as a servce) plays into the retail strategy for companies like Wal-Mart, T-Mobile, and Apple, and get some industry details from some of the insiders he spoke with.

Stocks: GDOT, AAPL, WMT, TMUS

To get 50% off our Stock Advisor service, go to http://IF.Fool.com

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Earnings season is now in the latter innings, but it wouldn’t be complete without discussing results from Mastercard (NYSE: MA), Berkshire Hathaway (NYSE: BRK-B), and Markel (NYSE: MKL). Plus, Fool.com contributor Matt Frankel, CFP discusses some interesting tax benefits of real estate investing, and he and host Jason Moser reveal the stocks that are on top of their watch lists.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Shares of Fitbit spiked this week after the company announced Google was buying the wearables maker for $2.1B. The acquisition marks a turning point in Google's approach to the wearables market, we explain what it could mean and hit recent earnings from Apple.Stocks: FIT, GOOG, GOOGL, AAPL

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

It’s Halloween and we’ve got a special show for you. Motley Fool Contributor Dan Kline joins the show and we break down our biggest fears in the market today, list out the stocks we think are going to turn into pumpkins, shared our zombie stocks that are set to come back from the dead, and then Dan, Nick, and Austin share their Mt. Rushmore of Halloween Candy.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Biogen's drug pipeline took a massive hit earlier this year when it stopped development of its Alzheimer's disease drug, aducanumab, for a lack of efficacy. Now, Biogen says new data shows it may work after all. Can this drug pass muster with regulators? Also, Walgreen's is closing retail clinics within its stores, but that doesn't mean it's giving up on plans to offer more healthcare services entirely.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

To get 50% off our Stock Advisor service, go to http://IF.Fool.com.

Founded by Katrina Lake in 2011, StitchFix has taken the fashion world by storm. By leveraging data science, StitchFix sends customers personalized “fixes” tailored toward their size and style, and the company has continued to innovate through new initiatives like its Style Shuffle game and new Direct Buy Program. We hope you’ll enjoy this conversation between StitchFix COO Mike Smith and the Motley Fool’s Tom Gardner, Andy Cross, and Tim Beyers. 

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

To get 50% off our Stock Advisor service, go to http://IF.Fool.com.